Resetting of aortic baroreceptors in response to hypotension does not alter gain sensitivity

Marcia K Koike1, Edson D Moreira, Gustavo J J da Silva

  • 1Hypertension Unit, Heart Institute (InCor), Medical School, University of São Paulo, São Paulo, Brazil.

Insights

Baroreceptors in rats with chronic hypotension reset normally without altered gain sensitivity. This finding explains the preserved baroreflex control of heart rate in hypotension, unlike in hypertension.

Area of Science:

  • Cardiovascular Physiology
  • Autonomic Nervous System Regulation

Background:

  • Baroreceptor resetting is well-documented in chronic hypertension, showing decreased gain sensitivity.
  • Limited data exists on baroreceptor function and gain sensitivity during chronic hypotension.
  • Myocardial infarction (MI) in rats can induce chronic hypotension without heart failure, serving as a model for study.

Purpose of the Study:

  • To investigate aortic baroreceptor function and baroreflex control of heart rate (HR) in a rat model of chronic hypotension induced by MI.
  • To determine if baroreceptor resetting in hypotension is associated with changes in gain sensitivity.
  • To compare baroreflex control of HR in hypotensive rats with control animals.

Main Methods:

  • Aortic baroreceptor function curves were assessed in anesthetized rats 7 and 30 days post-MI, alongside a sham-operated control group.
  • Pressure-nerve activity relationships were measured using computerized beat-to-beat analysis of integrated whole-nerve activity.
  • Baroreflex control of HR was evaluated by analyzing bradycardic and tachycardic responses.

Main Results:

  • Chronic hypotension (7 and 30 days post-MI) resulted in complete baroreceptor resetting, with the function curve shifting leftward to match the reduced blood pressure.
  • Baroreceptor resetting was not accompanied by significant changes in gain sensitivity across the groups (SHAM, MI-7, MI-30).
  • Baroreflex control of HR remained normal in rats with chronic hypotension compared to controls.

Conclusions:

  • Baroreceptor resetting in chronic hypotension is a stable process that does not alter gain sensitivity.
  • The preserved gain sensitivity in hypotension contributes to normal baroreflex control of heart rate.
  • Findings contrast with hypertension, where baroreceptor resetting involves decreased gain sensitivity.

Related Concept Videos

Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Measurement of Blood Pressure01:17

Measurement of Blood Pressure

Assessing blood pressure is a standard procedure executed in virtually all medical environments. The method utilized today was established over a hundred years ago by an innovative Russian doctor, Dr. Nikolai Korotkoff. The soft ticking noise, known as Korotkoff sounds, heard while taking blood pressure readings results from turbulent blood flow within the vessels. The apparatus required for this procedure includes a sphygmomanometer, a blood pressure cuff attached to a gauge, and a stethoscope.
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Autoregulation of Blood Flow01:17

Autoregulation of Blood Flow

Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...